PATHIOS THERAPEUTICS LIMITED
Company number 10641754 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Shareholders' funds
£45,729,623
Balance sheet as at 2025-12-31
Overview
- Company type
- Private Limited Company
- Incorporated
- 2017-02-27
- Employees
- 9 (2025 accounts · was 7 in 2024)
- Registered office
- 99 Park Drive, Milton, Abingdon, England, OX14 4RY
- Postcode
- OX14 4RY
- Capital
- 478 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2026-02-26
- Next due by
- 2027-03-12
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 6 current · 4 resigned
Group structure 1 subsidiary
From persons-with-significant-control filings on the public register.
Data protection registration
Registered with the ICO as a data protection fee payer — ZB491369 (Tier 1), registered since 2022.
Information Commissioner's Office register of fee payers, licensed under the Open Government Licence.
Contact details
- Website
- pathiostherapeutics.com
- Phone
- +44 1235 644960
Pioneering a novel macrophage conditioning approach to delivering breakthrough cancer therapies
Previous registered addresses 2
| Address | Changed on |
|---|---|
| 57 WOODSTOCK ROAD, OXFORD, OX2 6HJ, ENGLAND | 2019-05-21 |
| 16 GREAT QUEEN STREET, COVENT GARDEN, LONDON, WC2B 5AH, UNITED KINGDOM | 2018-08-08 |
Among its peers
Top 5%
by shareholders' funds, of 175 similar companies in OX
Trading since 2017.
No.5 of the largest research and experimental development on biotechnology companies in Oxford →
Competitors Oxford
This company ranks 5 among research and experimental development on biotechnology in Oxford.
The class of 2017
35%
of the 435 companies in this sector incorporated in 2017 are still active today; 61% have since been dissolved.
A fact about the year, not a forecast for this company.